All COVID-19 articles – Page 21
-
NewsTexas Biomed partners with Scancell to test novel COVID vaccine
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed).
-
NewsAttack on Mac1 Covid protein may lead to longer lasting live-attenuated vaccine
Research could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19.
-
NewsN-protein research reveals role of human body temperature in Covid proliferation
Researchers shed light on a pivotal part in the RNA-binding mechanism of the nucleocapsid protein (N) – SARS-CoV-2 probably uses human body temperature for its proliferation strategy.
-
NewsCommon cold virus exposure may help usher in immunity to Covid
Exposure to common cold-causing coronaviruses may contribute to pre-existing immunity to COVID-19, according to a new study.
-
NewsMolnupiravir dose of human effect size-equivalent blocks Covid transmission in ferrets
Two oral drugs provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission when administered at a human effect size-equivalent dose.
-
NewsModulating type 1 Interferon may expand treatment options for COVID-19
Researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body’s initial defenses against infection, impacts SARS-CoV-2 viral replication and disease progression.
-
NewsNew Drosophila toolkit to help reveal how Covid-19 virus impacts human health
Researchers have developed a toolkit of <i>Drosophila melanogaster</i> COVID-19 resources to study how viral and human proteins interact, with the goal of developing therapies for symptoms caused by existing and new strains.
-
OpinionNew RSV vaccines on the way - so what do we do about vaccine hesitancy?
Not one, but two promising new vaccines are likely to be introduced to the UK, yet routine childhood vaccination rates have been decreasing for ‘old’ diseases like measles and polio - what’s going on?
-
NewsModerna is safest, most effective mRNA vaccine against COVID-19 for older adults
A study of older US adults found that the risk of negative effects of both mRNA vaccines is exceptionally low, but lowest with the Moderna vaccine.
-
NewsAI-based wastewater sampling predicts COVID hospital admissions
Researchers have developed an accurate prediction tool for estimating COVID-19 hospital admissions, using an Artificial Intelligence (AI) based system with wastewater sampling.
-
NewsBreath test rapidly detects COVID-19 virus
Scientists have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a minute.
-
NewsCOVID-19 vaccination reduces severity and mortality after breakthrough infections
Among individuals recently infected with SARS-CoV-2, those who were fully vaccinated had lower concentrations of almost all inflammation markers (cytokines and chemokines) than those who were unvaccinated in the short-term and long-term after symptomatic SARS-CoV-2 infection.
-
NewsNewly discovered antibodies can neutralize COVID-19 variants
Scientists have isolated potent neutralizing antibodies from a COVID-19 vaccinated SARS survivor that exhibited remarkable breadth against known sarbecoviruses.
-
NewsSmaller magnetic beads with superior magnetic moment capture Covid virus more quickly
Scientists have developed a more efficient way to test SARS-CoV-2 Virus with a novel nano-immune magnetic bead (Mal-IMB) that can efficiently be bound to the pseudovirus in the study of protein biomimetic mineralization and synthesized into magnetic nanoparticles.
-
NewsFar UVC light could have disinfection potential against Covid variants
Scientists have investigated the inactivation efficacy of different UV wavelengths and assessed the safety profile for effective management of COVID-19 risks.
-
NewsSpike protein mutants with low binding affinity usher in new Covid vaccine
Researchers have succeeded in producing a new vaccine against the SARS-CoV-2 coronavirus by identifying spike protein mutants that lack binding affinity.
-
NewsInterferon could help reduce the spread of COVID-19
Results of an innovative clinical trial have shown that the drug interferon could help reduce the spread of COVID-19 from a positive person to their household contacts, with the study helping to inform treatment options for a future pandemic.
-
NewsFly toolkit created for investigating COVID-19 infection mechanisms
A new ‘fly-to-bedside’ resource offers a shortcut for developing drug therapies needed for long COVID and future coronavirus outbreaks.
-
NewsClose contact within households may not influence COVID-19 transmission
A study measuring the impact of close contact on SARS-CoV-2 virus transmission within households suggests that being in proximity to someone with the virus may not influence the likelihood of becoming infected.
-
NewsPicolinic acid reveals its broad-spectrum antiviral abilities
Picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses, according to a new study.